{"grounding": "Biological toxins are entrenched within ecosystems. Thus, animals are often exposed to such toxins, and how they adapt can be a key determinant of their evolutionary trajectories. In this review, we provide an overview of the diversity of toxin resistance mechanisms, with a focus on animals that sequester toxins from their diet and their natural predators and parasites. We propose a structured framework in which to study toxin resistance by recategorizing and reorganizing known mechanisms into avoidance, metabolism, and target categories. Then, using this framework, we review evidence regarding how animals resist four widely studied compounds: tetrodotoxin, batrachotoxin, cardiotonic steroids, and pyrrolizidine alkaloids. Based on the available data, we conclude that toxin resistance and sequestration are interrelated from both ecological and evolutionary perspectives. To conclude, we highlight open questions regarding toxin resistance and review its importance as a field.\nEn los ecosistemas las toxinas de origen biol\u00f3gico son componentes intr\u00ednsecos. Por esta raz\u00f3n, los animales se ven expuestos frecuenciamente a dichas toxinas y la forma en que se adaptan puede ser un factor que determina su trayectoria evolutiva. Esta revisi\u00f3n ofrece una visi\u00f3n general de la diversidad de mecanismos de resistencia a toxinas, centr\u00e1ndose en animales que secuestran toxinas de su dieta y en sus depredadores y par\u00e1sitos naturales. En este texto se propone un marco estructural para estudiar la resistencia a toxinas mediante la recategorizaci\u00f3n y reorganizaci\u00f3n de mecanismos conocidos en categor\u00edas de: evaci\u00f3n, metabolismo y mol\u00e9culas diana. A continuaci\u00f3n, utilizando este marco, revisamos la literatura cient\u00edfica en busca de evidencia sobre c\u00f3mo los animales resisten a cuatro compuestos ampliamente estudiados: tetrodotoxina, batracotoxina, esteroides cardiot\u00f3nicos y alcaloides de pirrolizidina. A partir de los datos disponibles, llegamos a la conclusi\u00f3n de que la resistencia y la retenci\u00f3n de toxinas est\u00e1n interrelacionadas tanto desde el punto de vista ecol\u00f3gico como evolutivo. Por \u00faltimo, destacamos algunas preguntas abiertas en torno a la resistencia a las toxinas y resaltamos su importancia como campo de estudio en el futuro.", "generated_text": "Toxin resistance is a critical adaptation that enables animals to survive in environments where toxic compounds are prevalent. This review explores the diverse mechanisms that animals have evolved to resist toxins, focusing on tetrodotoxin (TTX), batrachotoxin (BTX), cardiotonic steroids (CTS), and pyrrolizidine alkaloids (PAs). Tetrodotoxin, a potent neurotoxin, is found in various marine and terrestrial species, including pufferfish, newts, and salamanders. Resistance to TTX is primarily achieved through amino acid substitutions in voltage-gated sodium channels, which prevent the toxin from binding and blocking the channel. Batrachotoxin, another potent neurotoxin, is found in poison dart frogs and certain birds. Resistance to BTX involves similar modifications in sodium channels, but the specific amino acid changes differ from those seen in TTX-resistant species. Cardiotonic steroids, such as bufadienolides and cardenolides, are produced by plants and toads and can disrupt cardiac function. Resistance to CTS is often mediated by mutations in the Na+/K+-ATPase, the primary target of these toxins. Pyrrolizidine alkaloids, which are toxic to most animals, are sequestered by certain insects and used as a chemical defense. Resistance to PAs involves detoxification enzymes, such as cytochrome P450s, and the ability to store the toxins in specialized tissues. These mechanisms highlight the complexity and diversity of toxin resistance in the animal kingdom, providing insights into the evolutionary arms race between predators, prey, and their chemical defenses. Understanding these mechanisms not only sheds light on the biology of toxin resistance but also has implications for the development of novel therapeutic agents and the management of toxicological risks in human and veterinary medicine.", "label": 1}